356 related articles for article (PubMed ID: 25041770)
1. Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin.
Page SR; Yee KC
Intern Med J; 2014 Jul; 44(7):690-3. PubMed ID: 25041770
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
Molden E; Andersson KS
Pharmacotherapy; 2007 Apr; 27(4):603-7. PubMed ID: 17381388
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
Lee AJ; Maddix DS
Ann Pharmacother; 2001 Jan; 35(1):26-31. PubMed ID: 11197581
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.
Kahri AJ; Valkonen MM; Vuoristo MK; Pentikäinen PJ
Ann Pharmacother; 2004 Apr; 38(4):719. PubMed ID: 14966253
[No Abstract] [Full Text] [Related]
5. Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.
Wagner J; Suessmair C; Pfister HW
J Neurol; 2009 Jul; 256(7):1182-3. PubMed ID: 19252767
[No Abstract] [Full Text] [Related]
6. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.
Patel AM; Shariff S; Bailey DG; Juurlink DN; Gandhi S; Mamdani M; Gomes T; Fleet J; Hwang YJ; Garg AX
Ann Intern Med; 2013 Jun; 158(12):869-76. PubMed ID: 23778904
[TBL] [Abstract][Full Text] [Related]
7. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Li DQ; Kim R; McArthur E; Fleet JL; Bailey DG; Juurlink D; Shariff SZ; Gomes T; Mamdani M; Gandhi S; Dixon S; Garg AX
CMAJ; 2015 Feb; 187(3):174-180. PubMed ID: 25534598
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
Rowan C; Brinker AD; Nourjah P; Chang J; Mosholder A; Barrett JS; Avigan M
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):301-9. PubMed ID: 19206087
[TBL] [Abstract][Full Text] [Related]
10. [Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
Bastida C; Also MA; Pericas JM; Letang E; Tuset M; Miró JM
Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):579-82. PubMed ID: 24913991
[TBL] [Abstract][Full Text] [Related]
11. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.
Molden E; Skovlund E; Braathen P
Drug Saf; 2008; 31(7):587-96. PubMed ID: 18558792
[TBL] [Abstract][Full Text] [Related]
12. Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin.
Gruer PJ; Vega JM; Mercuri MF; Dobrinska MR; Tobert JA
Am J Cardiol; 1999 Oct; 84(7):811-5. PubMed ID: 10513779
[TBL] [Abstract][Full Text] [Related]
13. Potential drug interaction between simvastatin and danazol causing rhabdomyolysis.
Andreou ER; Ledger S
Can J Clin Pharmacol; 2003; 10(4):172-4. PubMed ID: 14712320
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A
Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159
[TBL] [Abstract][Full Text] [Related]
15. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.
Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M
Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728
[TBL] [Abstract][Full Text] [Related]
16. Interaction potential between clarithromycin and individual statins-A systematic review.
Hougaard Christensen MM; Bruun Haastrup M; Øhlenschlaeger T; Esbech P; Arnspang Pedersen S; Bach Dunvald AC; Bjerregaard Stage T; Pilsgaard Henriksen D; Thestrup Pedersen AJ
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):307-317. PubMed ID: 31628882
[TBL] [Abstract][Full Text] [Related]
17. [Maximal initial dose of simvastatin causing acute renal failure through rhabdomyolysis: risk factors, pathomechanism and therapy related to a case].
Deme D; Al-Hadad A; Varga T; Szántó E; Sándor K; Rakonczai E
Orv Hetil; 2009 Feb; 150(6):265-9. PubMed ID: 19179259
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
19. [88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].
Arnold Ch; Lamy O; Hagmann N
Praxis (Bern 1994); 2010 Dec; 99(24):1507-11. PubMed ID: 21125536
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis.
Kanathur N; Mathai MG; Byrd RP; Fields CL; Roy TM
Tenn Med; 2001 Sep; 94(9):339-41. PubMed ID: 11550401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
